Clinical course and symptomatic prediagnostic period of patients with Wegener's granulomatosis and microscopic polyangiitis

Renal Failure

Volumn 20, Issue 3, 1998, Pages 519-532

  Schleiffer, Thomas ^a,b   Burkhard, Bernd ^a   Klooker, Pieter ^a   Brass, Horst ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Long symptomatic prediagnostic period; Microscopic polyangiitis; Spontaneous disease course; Wegener's granulomatosis

Indexed keywords

CYCLOPHOSPHAMIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HEMOPTYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SYMPTOM; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0031924616     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045141     Document Type: Article

References (33)

1. Andrassy K, Küster S, Waldherr R, Ritz E: Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. Nephron 59:206-212, 1991.
2. Brass H., Schleiffer T: Renal involvement of systemic diseases. Nieren- und Hochdruckkrankheiten 18:40-46, 1989.
3. Walton EW: Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1:265-270, 1958
4. Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Clinical review. Ann Int Med 98:76-85, 1983.
5. Van der Woude FJ, Rasmussen N, Lobatto S, et al: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1:425-429, 1985.
6. Leavitt RY, Fauci AS, Bloch DA, et al: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 8:1101-1107, 1990.
7. Jennette JC, Falk RJ, Andrassy K, et al.: Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 37:187-192, 1994.
8. Marin J, Schleiffer T, Lampante L, de Leon F, de Mas R: Rare manifestation of Wegener's granulomatosis on the pars prostatica urethrae and the upper respiratory tract. Akt Urol (German) 27:235-237, 1996.
9. Briedigkeit L, Göbel U, Schneider W, Kettritz R, Natusch R: Wegener's granulomatosis. A retrospective multicenter study. Nieren- und Hochdruckkrankheiten 21:233-242, 1992.
10. Gans ROB, Kuizinga MC, Goldschmeding R, et al: Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies. Nephron 64:182-188, 1993.
11. Hoffman GS, Kerr GS, Leavitt RY, et al: Wegener granulomatosis: an analysis of 158 patients. Ann Int Med 116:488-498, 1992.
12. Matteson EL, Gold KN, Bloch DA, Hunder GG: Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis classification criteria cohort. Am J Med 101:129-134, 1996.
13. Case records of the Massachusetts General Hospital. Case 25-1939. N Engl J Med 320:1677-1686, 1989.
14. Wegener F: Über generalisierte, septische Gefässerkrankungen. Verh Dtsch Path Ges 29:202-210, 1936.
15. Wegener F: Über eme eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Path Anat 102:36-68, 1939.
16. Wegener F: Die pneumogene allgemeine Granulomatose - sog. Wegener'sche granulomatose. In: Staemmler M: Lehrbuch der speziellen pathologischen Anatomie von Kaufmann E, Ergänzungsband I 1/1, Berlin: W de Gruyter 1961:225-299.
17. Gross WL, Lüdemann G, Kiefer G, Lehmann H: Anticytoplasmic antibodies in Wegener's granulomatosis (letter). Lancet 1:806, 1986.
18. de Groot K, Reinhold-Keller E, Tatsis E, et al: Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis: Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 39:2052-2061, 1996.
19. Fienberg R: The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis. Hum Pathol 12:458-467, 1981.
20. Adam O, Wiesinger H: Clinical course of untreated Wegener's granulomatosis. Klin Wochenschr (German) 66:181-186, 1988.
21. Woodworth TG, Abuelo JG, Austin HA, Esparza A: Severe glomerulonephritis with late emergence of classic Wegener's granulomatosis. Report of 4 cases and review of the literature. Medicine 66:181-191, 1987.
22. Wegener F: About the so-called Wegener's granulomatosis with special reference to the generalized vascular lesions. Morgagni 1:5-23, 1968.
23. Yildizer K, Paydas S, Serin E, Sagliker Y: Wegener's granulomatosis complicated by pericardial tamponade and renal failure. Nephron 72:339-340, 1996.
24. Schiavone WA, Ahmad M, Ockner SA: Unusual cardiac complications of Wegener's granulomatosis. Chest 88:745-748, 1985.
25. Gerbracht DD, Savage RW, Scharff N: Reversible vavulitis in Wegener's granulomatosis. Chest 92:182-183, 1987.
26. Rivera M, Gonzalez C, Gonzalo A, Quereda C, Fogue L, Ortuno J: Vasculitis associated with non-Hodgkin's lymphoma. Nephron 65:167-168, 1993.
27. Largiader A: Wegener'sche Granulomatose. Schweiz Med Wschr. 94:1000-1003, 1964.
28. Middleton G, Karp D, Lee E, Cush J: Wegener's granulomatosis presenting as lower back pain with prostatitis and ureteral obstruction. J Rheumatol 21:566-569, 1994.
29. Gross WL, Reinhold-Keller E: ANCA-associated vasculititdes (Wegener's granulomatosis, Churg-Strausssyndrome, microscopic polyangiitis) 1. Pathogenetic and clinical aspects. Z Rheumatol 54:279-290, 1995.
30. Watts RA, Joliffe VA, Carruthers DM, et al.: Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangutis. Arthritis Rheum 39:1208-1212, 1996.
31. Stegeman CA, Tervaert JWC, Jong PE, Kallenberg CGM, for the Dutch cotrimoxazole Wegener study group: Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 335:16-20, 1996.
32. Nowack R, Birck R, van der Woude FJ: Mycophanolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 349:774, 1996.
33. Andrassy K, Erb A, Koderisch J, et al.: Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy, and renal outcome. Clin Nephrol 35:139-147, 1991.